EA
JAZZ icon

Emerald Acquisition’s Jazz Pharmaceuticals JAZZ Stock Holding History

Emerald Acquisition’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$5.44M Sell
44,760
-17,945
-29% -$2.42M 0.01% 1157
2016
Q2 		$8.86M Buy
+62,705
New +$9.24M 0.02% 997

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's JAZZ Position: Q3 2016 in Review

Emerald Acquisition reduced its Jazz Pharmaceuticals (JAZZ) stake by 29% in Q3 2016, selling an estimated $2.42M and leaving 44,760 shares worth $5.44M. The position accounts for 0.01% of the portfolio, ranked #1157.

Emerald Acquisition first reported a position in JAZZ in Q2 2016 and has held it in 2 quarters since. The position peaked at $8.86M in Q2 2016. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • Emerald Acquisition held 44,760 shares of Jazz Pharmaceuticals worth $5.44M as of Q3 2016.
  • Emerald Acquisition sold 17,945 Jazz Pharmaceuticals shares in Q3 2016, an estimated $2.42M.
  • Jazz Pharmaceuticals made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1157 holding.
  • Emerald Acquisition first reported a position in Jazz Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Jazz Pharmaceuticals position peaked at $8.86M in Q2 2016.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.